Dolby Laboratories Inc (NYSE:DLB) shares, rose in value on Friday, May 30, with the stock price down by -0.99% to the previous day’s close as strong demand from buyers drove the stock to $74.26.
Actively observing the price movement in the last trading, the stock closed the session at $75.00. The PE ratio was 28.10 over 12-month period. Referring to stock’s 52-week performance, its high was $89.66, and the low was $66.35. On the whole, DLB has fluctuated by -3.29% over the past month.
With the market capitalization of Dolby Laboratories Inc currently standing at about $7.13 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June. The company’s Forward Dividend Ratio is 1.29, with its dividend yield at 1.74%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that DLB’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 4.47, with the price of DLB currently trading nearly -1.89% and -2.32% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.71, while the 7-day volatility ratio is showing 1.13% which for the 30-day chart, stands at 1.21%. Furthermore, Dolby Laboratories Inc (DLB)’s beta value is 0.93, and its average true range (ATR) is 1.34.
A comparison of Dolby Laboratories Inc (DLB) with its peers suggests the former has fared considerably weaker in the market. DLB showed an intraday change of -0.99% in last session, and over the past year, it shrunk by -6.34%%.
Data on historical trading for Dolby Laboratories Inc (NYSE:DLB) indicates that the trading volumes over the past 3 months, they’ve averaged 441.50K. According to company’s latest data on outstanding shares, there are 61.40 million shares outstanding.
Nearly 36.91% of Dolby Laboratories Inc’s shares belong to company insiders and institutional investors own 59.75% of the company’s shares. The stock has fallen by -4.92% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the DLB stock heading into the next quarter.
